Side-by-side comparison of AI visibility scores, market position, and capabilities
San Francisco pioneer DTC online eyewear at $6.95+ complete glasses with 50M+ pairs sold; privately-held disrupting traditional optical retail competing with Warby Parker and EyeBuyDirect for affordable prescription glasses online.
Zenni Optical is a San Francisco-based direct-to-consumer online eyewear retailer — privately held, founded in 2003 by Jing Wang and Julia Zhen — pioneering the online prescription glasses market by offering hundreds of frame styles with prescription lens fulfillment starting from as low as $6.95, making vision correction accessible at a fraction of the $200-800+ price of traditional optical retail. Estimated at $400+ million in annual revenue with 50+ million pairs of glasses sold to 50+ million customers in over 50 countries, Zenni's low-cost manufacturing (frames produced at owned factories in China) and direct-to-consumer model (no distributor or retailer markup layers) enable the dramatic price advantage over LensCrafters, Sunglass Hut, and independent opticians that made Zenni one of the first successful DTC disruptors.
Richmond VA tobacco and nicotine (NYSE: MO) ~$9.7B net revenue FY2024; Marlboro 40%+ US cigarette share, on! oral pouch competing with Zyn, 50%+ operating margins, ABI stake, competing with Reynolds/BAT.
Altria Group, Inc. is a Richmond, Virginia-based tobacco and nicotine company — publicly traded on the New York Stock Exchange (NYSE: MO) as an S&P 500 Consumer Staples component — manufacturing and selling cigarettes (Marlboro — the best-selling cigarette brand in the United States), smokeless tobacco (Copenhagen, Skoal, Red Seal, Husky chewing tobacco/moist snuff brands), oral nicotine pouches (on! brand), and maintaining a 10.7% ownership stake in Anheuser-Busch InBev (SABMiller acquisition consideration shares) and a 35% stake in JUUL Labs (vaping — original $12.8B investment written down to minimal value following JUUL's regulatory and litigation difficulties) through approximately 5,500 employees. In fiscal year 2024, Altria reported revenues of approximately $20.6 billion (net revenues after excise taxes approximately $9.7 billion), with the cigarette segment (Marlboro generating 40%+ US cigarette market share) contributing the majority of operating income at 50%+ adjusted operating margins — the highest margins in the consumer staples sector reflecting cigarettes' inelastic demand and regulated market structure. CEO Billy Gifford has pivoted Altria's strategy from cigarettes toward smoke-free nicotine products: the on! oral nicotine pouch (acquired full ownership of Helix Innovations in 2023, rebranding as on! to compete with Swedish Match Zyn, the dominant US oral nicotine pouch brand) represents Altria's primary nicotine product diversification vehicle as cigarette volume declines 7-8% annually through consumer quit rates and secular health awareness trends.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.